Clinical Trials Logo

Clinical Trial Summary

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.


Clinical Trial Description

Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea. Inclusion criteria 1. Over 20 years old. 2. It is determined by the physician to meet the final diagnosis conditions. 3. Symptoms of dyspnea. 4. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points. 5. Able to communicate in Mandarin or Taiwanese or written conversation. 6. Unconscious disorder. 7. After explaining and explaining, agree to participate in this research and sign the consent form. Exclusion criteria 1. Receive treatment for facial trigeminal nerve damage. 2. Abnormal sense of smell. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05625854
Study type Interventional
Source Taipei Medical University
Contact
Status Enrolling by invitation
Phase N/A
Start date November 25, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Recruiting NCT04750395 - Comparing Haloperidol and Olanzapine in Treating Terminal Delirium Phase 2
Recruiting NCT06108375 - Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof N/A
Completed NCT04030910 - 'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life N/A
Completed NCT04568629 - ADJUST: A Study on MDT Prognostication N/A
Completed NCT03520270 - Prevalence of Potentially Inappropriate Treatments
Recruiting NCT04257227 - Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness N/A
Completed NCT04678310 - iLIVE Volunteer Study
Completed NCT04456647 - Parenteral Nutrition Therapy in Patients With Incurable Cancer
Completed NCT02362295 - Prospective National Survey of the Palliative Situation Among Inmates in French Prisons N/A
Terminated NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Active, not recruiting NCT04950608 - Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Phase 2
Completed NCT03336489 - Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
Completed NCT03392857 - End Of Life in the Critically Ill patiEnt
Completed NCT03697213 - The Surprise Study
Completed NCT01367613 - Open-Label Treatment Extension of Protocol MNTX 302 Phase 3
Recruiting NCT04612738 - Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations N/A
Completed NCT02067572 - A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care N/A
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Terminated NCT03616639 - Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function Phase 4